Loading...
Aster DM Healthcare has launched the Aster Al Raffah International Comprehensive Cancer Care Centre in Muscat, Oman, aiming to provide advanced, subspecialized oncology services within the country.
Addressing the Need for Localized Cancer Care
Historically, many Omani patients traveled abroad for specialized cancer treatments, facing physical, emotional, and financial challenges. Alisha Moopen, Managing Director and Group CEO of Aster DM Healthcare GCC, emphasized the importance of accessible care, stating that patients should receive top-quality treatment without leaving their home country.
Subspecialization: A Targeted Approach
The center adopts a subspecialized methodology, ensuring patients are treated by experts in specific cancer types. This approach includes dedicated specialists for various cancers, such as head and neck, gastrointestinal, breast, colorectal, and urological cancers. Moopen highlighted that this targeted care ensures optimal treatment tailored to each patient's condition.
Multidisciplinary Collaboration
Aster's model integrates a Tumor Board and a Multidisciplinary Team (MDT), comprising medical oncologists, surgical oncologists, and radiation specialists. This collaborative framework allows for the development of personalized treatment plans, ensuring comprehensive patient care.
Technological Integration and Early Detection
The center emphasizes the importance of early detection and the use of advanced technologies in cancer treatment. By incorporating cutting-edge diagnostic tools and treatment modalities, the facility aims to improve patient outcomes and enhance the overall quality of care.
The establishment of the Aster Al Raffah International Comprehensive Cancer Care Centre represents a significant advancement in Oman's healthcare landscape, offering residents access to world-class cancer care within their own country.
